p97/UBXD1 Generate Ubiquitylated Proteins That Are Sequestered into Nuclear Envelope Herniations in Torsin-Deficient Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Apr 2022
Historique:
received: 26 02 2022
revised: 14 04 2022
accepted: 20 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

DYT1 dystonia is a debilitating neurological movement disorder that arises upon Torsin ATPase deficiency. Nuclear envelope (NE) blebs that contain FG-nucleoporins (FG-Nups) and K48-linked ubiquitin are the hallmark phenotype of Torsin manipulation across disease models of DYT1 dystonia. While the aberrant deposition of FG-Nups is caused by defective nuclear pore complex assembly, the source of K48-ubiquitylated proteins inside NE blebs is not known. Here, we demonstrate that the characteristic K48-ubiquitin accumulation inside blebs requires p97 activity. This activity is highly dependent on the p97 adaptor UBXD1. We show that p97 does not significantly depend on the Ufd1/Npl4 heterodimer to generate the K48-ubiquitylated proteins inside blebs, nor does inhibiting translation affect the ubiquitin sequestration in blebs. However, stimulating global ubiquitylation by heat shock greatly increases the amount of K48-ubiquitin sequestered inside blebs. These results suggest that blebs have an extraordinarily high capacity for sequestering ubiquitylated protein generated in a p97-dependent manner. The p97/UBXD1 axis is thus a major factor contributing to cellular DYT1 dystonia pathology and its modulation represents an unexplored potential for therapeutic development.

Identifiants

pubmed: 35563018
pii: ijms23094627
doi: 10.3390/ijms23094627
pmc: PMC9100061
pii:
doi:

Substances chimiques

Adaptor Proteins, Vesicular Transport 0
Autophagy-Related Proteins 0
Molecular Chaperones 0
Nuclear Pore Complex Proteins 0
Nuclear Proteins 0
TOR1A protein, human 0
UBXN6 protein, human 0
Ubiquitin 0
Adenosine Triphosphatases EC 3.6.1.-
p97 ATPase EC 3.6.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : R01GM114401
Pays : United States
Organisme : United States Department of Defense
ID : PR200788
Organisme : NIH HHS
ID : 5T32GM007223
Pays : United States
Organisme : NIH HHS
ID : F31NS120528
Pays : United States
Organisme : Dystonia Medical Research Foundation
ID : NA

Références

J Biol Chem. 2015 Nov 20;290(47):28175-28188
pubmed: 26463207
Nat Cell Biol. 2011 Aug 07;13(9):1116-23
pubmed: 21822278
J Biol Chem. 2009 Oct 9;284(41):27866-27874
pubmed: 19651773
Nat Cell Biol. 2022 Nov;24(11):1584-1594
pubmed: 36302971
FEBS Lett. 2015 Sep 14;589(19 Pt A):2578-89
pubmed: 26320413
Semin Cell Dev Biol. 2019 Sep;93:111-124
pubmed: 30278225
J Cell Biol. 2003 Jul 7;162(1):71-84
pubmed: 12847084
Mol Cell Proteomics. 2012 Jun;11(6):M111.016444
pubmed: 22337587
Science. 2021 Jun 25;372(6549):eabc3593
pubmed: 34739326
Biochem Biophys Res Commun. 2009 May 1;382(2):303-8
pubmed: 19275885
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):E1545-54
pubmed: 23569223
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):847-52
pubmed: 14711988
Eur J Biochem. 1997 Oct 15;249(2):427-33
pubmed: 9370350
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9119-24
pubmed: 21571647
Biomolecules. 2020 Mar 19;10(3):
pubmed: 32204310
Mol Syst Biol. 2007;3:89
pubmed: 17353931
Elife. 2016 Jun 23;5:
pubmed: 27336722
Nature. 1997 Jul 3;388(6637):75-8
pubmed: 9214505
Nat Cell Biol. 2020 Mar;22(3):274-281
pubmed: 32094691
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7612-7
pubmed: 15136718
Elife. 2016 Aug 04;5:
pubmed: 27490483
Methods Enzymol. 2019;619:47-69
pubmed: 30910029
Hum Mol Genet. 2018 Feb 1;27(3):407-420
pubmed: 29186574
Neuron. 2005 Dec 22;48(6):923-32
pubmed: 16364897
Crit Rev Biochem Mol Biol. 2015;50(6):532-49
pubmed: 26592310
Sci Rep. 2018 Aug 17;8(1):12415
pubmed: 30120381
EMBO J. 2017 Jan 17;36(2):135-150
pubmed: 27753622
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
EMBO J. 2003 Aug 1;22(15):3783-91
pubmed: 12881413
BMC Bioinformatics. 2021 Sep 10;22(1):433
pubmed: 34507520
Trends Cell Biol. 2021 Jun;31(6):473-484
pubmed: 33531207
Mol Biol Cell. 2015 May 1;26(9):1752-63
pubmed: 25739455
Elife. 2020 Jun 26;9:
pubmed: 32588820
Nat Commun. 2011 Jul 12;2:393
pubmed: 21750546
Front Mol Biosci. 2017 Jun 13;4:39
pubmed: 28660197
Nature. 2017 Aug 17;548(7667):352-355
pubmed: 28682307
J Clin Invest. 2019 Aug 13;129(11):4885-4900
pubmed: 31408437
Science. 2019 Aug 2;365(6452):
pubmed: 31249135
Science. 2020 Apr 24;368(6489):
pubmed: 32327568
Curr Opin Struct Biol. 2014 Feb;24:24-33
pubmed: 24721450
Nature. 2002 Apr 18;416(6882):763-7
pubmed: 11961560
Hum Mol Genet. 2015 Nov 15;24(22):6459-72
pubmed: 26370418
Neurobiol Dis. 2019 Jul;127:233-241
pubmed: 30877032
J Med Chem. 2015 Dec 24;58(24):9480-97
pubmed: 26565666
Nature. 2000 Apr 13;404(6779):770-4
pubmed: 10783891
Mol Biol Cell. 2016 Dec 15;27(25):3964-3971
pubmed: 27798237
Nat Genet. 1997 Sep;17(1):40-8
pubmed: 9288096
Trends Biochem Sci. 2021 Aug;46(8):630-639
pubmed: 33509650
Elife. 2014 Aug 22;3:e03239
pubmed: 25149450
EMBO J. 1987 Jan;6(1):55-61
pubmed: 3034579
Mol Cell. 2009 Oct 9;36(1):28-38
pubmed: 19818707
Nat Rev Mol Cell Biol. 2019 Nov;20(11):665-680
pubmed: 31253954
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):E4822-31
pubmed: 25352667
Mol Cell. 2018 Jan 18;69(2):182-194
pubmed: 29153394
Oncotarget. 2015 Dec 15;6(40):42854-67
pubmed: 26536657
EMBO J. 2011 Jul 22;30(16):3217-31
pubmed: 21785409
Elife. 2020 Mar 23;9:
pubmed: 32202496
J Cell Biol. 2020 Jun 1;219(6):
pubmed: 32342107
Cell. 2014 Mar 27;157(1):52-64
pubmed: 24679526
J Cell Biol. 2005 Mar 14;168(6):855-62
pubmed: 15767459
EMBO J. 2021 Sep 1;40(17):e106914
pubmed: 34313336
Nat Commun. 2018 Mar 22;9(1):1188
pubmed: 29568061
Curr Opin Cell Biol. 2018 Aug;53:22-28
pubmed: 29719269
Cancer Cell. 2015 Nov 9;28(5):653-665
pubmed: 26555175
J Clin Invest. 2014 Jul;124(7):3080-92
pubmed: 24937429
Mol Cell. 2022 Feb 3;82(3):570-584.e8
pubmed: 34951965
J Med Chem. 2020 Mar 12;63(5):1892-1907
pubmed: 31550150

Auteurs

Sarah M Prophet (SM)

Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06520, USA.

Brigitte S Naughton (BS)

Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06520, USA.

Christian Schlieker (C)

Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06520, USA.
Department of Cell Biology, Yale School of Medicine, New Haven, CT 06520, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH